glenpyle

Home/Glen Pyle

About Glen Pyle

Glen Pyle, PhD is a Professor of Molecular Cardiology at the University of Guelph and an Associate Member of the IMPART Team Canada Investigator Network at Dalhousie Medicine.
6 01, 2021

Are COVID-19 vaccines a rush job? Explaining the speed of vaccine development

By |2021-02-12T00:09:34-05:00January 6th, 2021|Vaccines and Therapeutics|0 Comments

It turns out that things may not be as they appear when it comes to the speed of COVID-19 vaccine development. The reality is that COVID-19 vaccines are based on years of documented research that created the critical knowledge, infrastructure, and cutting-edge technology that made rapid vaccine production possible.

24 11, 2020

Vaccination Opponents Drive An Epidemic Of COVID-19 Misinformation

By |2021-02-16T17:28:24-05:00November 24th, 2020|Vaccines and Therapeutics|0 Comments

There is a saying that when all you have is a hammer, everything looks like a nail. So, it should come as no surprise that vaccine skeptics worldwide are sounding the alarm about the flu shot as a real danger in the COVID-19 pandemic. Confused? Well, it turns out the anti-vaccine activists are too.

19 10, 2020

Regeneron Antibodies: Fact-Checking the Science of an Experimental COVID-19 Treatment

By |2021-02-16T17:22:06-05:00October 19th, 2020|Vaccines and Therapeutics|0 Comments

In January, 2020, during the earliest days of the COVID-19 pandemic, a US-based research scientist was exposed to SARS-CoV-2, the virus responsible for the disease, at a family gathering in Beijing. Within months, samples provided by this anonymous scientist helped to kick-start research in antibody-based treatments for COVID-19 that ultimately lead to an experimental antibody treatment received by US President Donald Trump.

21 09, 2020

COVID-19 Ups The Chances Of Dying From A Broken Heart

By |2021-02-16T17:24:00-05:00September 21st, 2020|Fundamental Science|0 Comments

Although COVID-19 is a respiratory illness, a new review of COVID-19 studies published in the journal PLoS One shows that cardiovascular complications are common in COVID-19 patients, which might increase the risk of death.

7 08, 2020

Will COVID-19 Use Myocarditis to Strike Out Baseball?

By |2021-02-12T00:23:42-05:00August 7th, 2020|Fundamental Science|0 Comments

COVID-19 has thrown North American professional baseball a curveball. An outbreak among players for the Miami Marlins, that has spread to the Philadelphia Phillies and St. Louis Cardinals, brings into question the infection control protocols touted by Major League Baseball. But perhaps more concerning is the report that Boston Red Sox pitcher Eduardo Rodríguez developed myocarditis as a result of COVID-19. Will myocarditis from COVID-19 be a strike out pitch for professional baseball?

17 07, 2020

The Ups and Downs of Hydroxychloroquine

By |2021-02-12T00:25:11-05:00July 17th, 2020|Vaccines and Therapeutics|0 Comments

As COVID19 continues to spread, the global search for a cure is underway. The development of a preventative vaccine is likely months if not a year away. In the meantime, several therapies have been raised as potential cures with hydroxychloroquine arguably being the most widely known. But will this miracle treatment live up to the hype?

Go to Top